Parallel6 Named One of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook

Share Article

Parallel6 wins top 10 eClinical Trial Management Solution Providers for the second year in a row. Parallel6 is the leader in mClinical technologies for improving patient enrollment, engagement, and management of clinical trials worldwide.

Parallel 6

Parallel 6

To date the top pharmaceutical companies and CROs have recognized how our technology platform is revolutionizing the way clinical trials are conducted. - Allan Camaisa, CEO and Chairman of Parallel6

Parallel6™, the leader in mClinical™ technologies for improving patient enrollment, engagement, and management of clinical trials worldwide, announced today that they were named one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook magazine, which covers the latest developments in the pharmaceutical industry.

“We take pride in honoring Parallel6 as one of the top 10 companies that are specializing in providing eClinical Trial Management solutions for Pharmaceutical Companies,” said Stacey Smith, Managing Editor of Pharma Tech Outlook. “The team at Parallel6 has developed a technology that supersedes the current technology used in clinical trials and bridges the gaps formed in patient interaction on a daily basis.”

The Clinical6™ platform is an end-to-end solution that empowers potential clinical trial participants to digitally qualify, consent, enroll, and engage in a clinical trial using any internet enabled device, virtually eliminating delays, errors, and other issues. Clinical6 operates in a secure HIPAA compliant cloud, is 21 CFR Part 11 / Annex 11 compliant and has been independently audited.

“We are excited to see the continued momentum behind Clinical6. To date the top pharmaceutical companies and CROs have recognized how our technology platform is revolutionizing the way clinical trials are conducted. Our platform gives clinical trial stakeholders real-time access to the data they need to make informed decisions quicker,” said Allan Camaisa, CEO and Chairman of Parallel6.

“Clinical6 is a unified clinical platform that enables virtual, hybrid, and site-based clinical studies in multi-language, multi-country configurations anywhere in the world,” said President and CTO | Founder of Parallel6, David Turner.

For more information on how Clinical6 is leveraging mobile technologies to streamline clinical trials, check out our recent webinars here.

About Parallel6
Parallel6™, is an innovative software as a service provider of mobile enrollment and engagement solutions for clinical research, health, and public sector organizations. Clinical6™ is an mClinical™ platform for patient enrollment, engagement, and management of clinical trials worldwide. Additional solutions include GovReach™ for government agencies. GovReach accelerates government-to-citizen and internal government digital efficiency, transparency, and engagement. The firm’s headquarters is in San Diego, CA with additional offices in Washington D.C. For more information, visit http://www.parallel6.com/.

About Pharma Tech Outlook
Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industry. A panel of experts and members of Pharma Tech Outlook’s editorial board selected and finalized the “Top 10 eClinical Trial Management Solution Providers 2017” and shortlisted the best vendors and consultants. For more info:  http://www.pharmatechoutlook.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eucce
@Parallel6
Follow >
Visit website